Proteome Sciences Share Discussion Threads

[wasjobber] 06/1/2023 07:52

Revenues from the soon to be released new worlds first Stroke blood tests will be considerable. We know the royalty rate is at least 10% from the Randox Stroke blood test and the global Stroke blood test market is estimated to be $1bn - $1.5bn

We also have important Alzheimer's disease biomarkers which are of even greater value to Proteome Sciences.

Also, watch out for a new technology licensing deal.

[elpirata] 05/1/2023 23:13

Wow, only another 13 x £870k milestone payments and they can pay off the company debts to CJP & Diggle so profits can then start to reflect in the sp

[dominiccummings] 05/1/2023 15:28

Well done JJ, Uncle Gary would be thrilled!

[james japp] 05/1/2023 15:25

91919

Boom!

[james japp] 05/1/2023 15:25

Uncle Gary/Garry, Dom.

[dominiccummings] 05/1/2023 15:11

Uncle something, isn't it?

[peverill] 05/1/2023 11:40

Good Grief!!!,heard from who,???

[james japp] 05/1/2023 10:57

2 upticks and some PlusCoin in 3 minutes.

Impressive on a thread that is practically dead in the water.

[james japp] 05/1/2023 10:56

Similar to what?

The avatar didnt 'say' anything at all.

[wasjobber] 05/1/2023 10:53

pools2,

I agree, I've heard something similar. This is going to be a significant year for Proteome Sciences growth.

BUY

[monte1] 05/1/2023 09:42

Indeed pools2, although you have been ‘thinking̵7; that for more than a decade now so I am not sure that I can attach much weight to your thoughts.

[pools2] 05/1/2023 09:40

I think we'll be getting some very good news soon.

[bluemango] 05/1/2023 09:13

Don't knock it.

It's a bit like a proof of life event, in a kidnapping.

[james japp] 05/1/2023 08:40

Were these the same milestones that one totally discredited avatar claimed and indeed argued both vociferously and endlessly that those milestones were worth many, many multiples of the true value, despite it being completely obviously to all and sundry what the actual score was?

[monte1] 05/1/2023 08:34

Well that has* shaken the market from its slumber.







*hasn’t

[peverill] 05/1/2023 07:16

That should keep them in teabags for a few months.

[james japp] 04/1/2023 13:03

I note there has been a flurry of trade, buying too.

[wasjobber] 03/1/2023 22:08

The UCLH trial was not abandoned, it was "suspended" due to Covid-19, along with many other trials.



The UCLH trial restarted last year, although there are other trials for the Randox Stroke test more advanced than UCLH.

[elpirata] 03/1/2023 21:55

The UCL stroke validation trial was abandoned in 2021, did it ever restart?

Edit; this is it

[peverill] 03/1/2023 20:26

If that was the case,why didn't PRM inform the market?.And if also the case why didn't someone get the ball rolling re the CE mark process,so it was ready when pandemic started to relax.As always with this company transparency seems elusive and random shareholders seem to be the place to go for info if they can be believed,no disrespect.;-)

[wasjobber] 03/1/2023 19:24

The Randox Stroke test was due to be released in 2020, but when Covid-19 hit R&D at Randox was halted and all manpower was diverted to help with the pandemic, with Randox gaining large lucrative testing contracts. Apparently, there is now "mountains of interest" from customers wanting the Randox Stroke test and including the recent website updates its obvious that the stroke test release is looming.

[goatherd] 03/1/2023 19:15

I don't agree Pram. I think Randox have money coming out of their ears from their Covid testing work. I suspect that is why they haven't bothered much with stroke.

Either laziness, or, more likely, a shortage of managers.